+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Rhythm Management Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 4591322
  • Report
  • May 2020
  • Region: Global
  • 114 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Abiomed
  • Biotronik SE & Co KG
  • Koninklijke Philips NV
  • LivaNova Plc
  • Medtronic PLC
  • MORE
The cardiac rhythm management devices market is expected to witness a CAGR of 4.8% during the forecast period. Certain factors that are driving the market growth include the increasing prevalence of cardiovascular disorders, technological advancements, a rise in the use of ambulatory and home services for cardiac monitoring, and favorable reimbursement policies.

The increasing instance of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market. According to the World Health Organization (WHO), globally, cardiovascular diseases account for more than 30% of deaths. Also, nearly 33.5 million people, globally, are suffering from atrial fibrillation (AFib), which is the most common type of serious arrhythmia. With the rise in the aging population in America and Europe, a number of patients suffering from heart rhythm disorders are likely to witness an increase and this is a cause for concern.

However, the therapeutic radiation used in cancer treatment can influence the operation of a patient with implantable cardiac rhythm devices. The implantable device technology uses complementary metal-oxide-semiconductor (CMOS) which are vulnerable to damage by the therapeutic doses of radiation, but it can vary according to the type of device in use. This factor is one of the major factors that limits the scope of using cardiac rhythm management devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. On the other hand, the high cost of these devices with limited insurance coverage is limiting the growth of the market.

Key Market Trends

Defibrillator is Expected to Hold the Largest Market Share in the Product Type

Defibrillator is a medical device that restore a normal heartbeat by sending an electric pulse or shock to the heart. This device is used to treat cardiac ocndition such as arrhythmia, a heartbeat that is uneven or that is too slow or too fast.

The use of defibrillator is increasing due to its efficacy in treating cardiac arrest. There was a survey conducted by the researchers during year 2018 which had 49,555 cardiac arrests across the USA and Canada that did not happen in hospitals. Among these people, around 18.8% of the people were survived due to AED (Automated external defibrillator) which were used by a bystander. Cardiac arrest victims who received a shock from a publicly-available AED had far more chances of survival and being discharged from the hospital than those who did not, accounting for 66.5% versus 43%. With ushc surveyes, it has been estimated that about 1,700 lives are saved in the United States every year by bystanders using a defibrillator. This indicates that the usage of defibrillators has experienced a significant rise, globally, over the recent years.

North America Dominates the Market and is Expected to do Same in the Forecast Period

North America is expected to have the largest market share for cardiac rhythm management, due to the developed healthcare infrastructure, government initiatives, and rising incidence of arrhythmias demanding more cardiac implants.

According to a report by the US CDC (2017), more than 75,000 hospitalizations are attributed to atrial fibrillation. Also, it is highlighted that a large part of the American population suffers from atrial fibrillation. Therefore, it is expected to rise further in the forecast period.

Asia-Pacific is another region with high potential for this market, due to the rising healthcare expenditure by the government, the increasing the prevalence of cardiac disorders, and the growing per capita income of the population in the South Asian countries.

Competitive Landscape

The cardiac rhythm management devices market is highly competitive and consists of a few major players. Companies like Abbott, Abiomed, Biotronik SE & Co KG, Boston Scientific Corporation, Koninklijke Philips NV, LivaNova Plc, Medtronic PPLC, SchillerAG, Shenzhen Mindray Biomedical Electronics Co. Ltd, and Zoll Medical Corporation, among others, hold the substantial market share in the cardiac rhythm management devices market.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Abiomed
  • Biotronik SE & Co KG
  • Koninklijke Philips NV
  • LivaNova Plc
  • Medtronic PLC
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Cardiovascular Disorders
4.2.2 Technological Advancements
4.2.3 Rise in the Use of Ambulatory and Home Services for Cardiac Monitoring
4.3 Market Restraints
4.3.1 Effects of Therapeutic Radiation on Implantable Cardiac Rhythm Devices
4.3.2 High Cost of Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Product
5.1.1 Defibrillators
5.1.1.1 Implantable Cardioverter Defibrillators (ICDS)
5.1.1.2 External Defibrillators (ED)
5.1.2 Pacemakers
5.1.2.1 Implantable Pacemakers (ICPS)
5.1.2.2 External Pacemakers
5.1.3 Cardiac Resynchronization Therapy Devices
5.1.3.1 Cardiac Resynchronization Therapy Defibrillators (CRT-D)
5.1.3.2 Cardiac Resynchronization Therapy Pacemakers (CRT-P)
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Abiomed
6.1.3 Biotronik SE & Co KG
6.1.4 Boston Scientific Corporation
6.1.5 Koninklijke Philips NV
6.1.6 LivaNova Plc
6.1.7 Medtronic PLC
6.1.8 SchillerAG
6.1.9 Shenzhen Mindray Biomedical Electronics Co., Ltd
6.1.10 Zoll Medical Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories
  • Abiomed
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova Plc
  • Medtronic PLC
  • SchillerAG
  • Shenzhen Mindray Biomedical Electronics Co., Ltd
  • Zoll Medical Corporation
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll